Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child

Pediatr Cardiol. 2020 Apr;41(4):843-845. doi: 10.1007/s00246-019-02245-6. Epub 2019 Nov 12.

Abstract

We describe the case of a novel PRKAG2 mutation that manifested with a ventricular fibrillation cardiac arrest in a child. The previously healthy 13-year old boy, was subsequently diagnosed with Wolff-White-Parkinson syndrome, mild left ventricular hypertrophy and atrial fibrillation. His father had also been diagnosed in the past with Wolff-White-Parkinson syndrome and developed left ventricular hypertrophy. A novel heterozygous likely pathogenic variant, c.911C>G, p.Ala304Gly was identified in the father and his son, which is absent from population databases. PRKAG2 gene variants have previously been shown to cause a familial syndrome of ventricular hypertrophy, ventricular pre-excitation, supraventricular tachycardia, and conduction abnormalities. However, to the best of our knowledge, this is the first description of this rare syndrome manifesting with a more severe phenotype in a second generation relative within the same family.

Keywords: Cardiac arrest; Child; PRKAG2; Wolff-White-Parkinson syndrome.

Publication types

  • Case Reports

MeSH terms

  • AMP-Activated Protein Kinases
  • Adolescent
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / diagnosis*
  • Atrial Fibrillation / genetics
  • Child
  • Electrocardiography
  • Heart Arrest / etiology*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Hypertrophy, Left Ventricular / complications
  • Hypertrophy, Left Ventricular / diagnosis*
  • Hypertrophy, Left Ventricular / genetics
  • Male
  • Mutation
  • Pedigree
  • Wolff-Parkinson-White Syndrome / complications
  • Wolff-Parkinson-White Syndrome / diagnosis*
  • Wolff-Parkinson-White Syndrome / genetics

Substances

  • PRKAG2 protein, human
  • AMP-Activated Protein Kinases